Submitted by kBLASTER Team on
Posted by Ambient Clinical Analytics
Rochester, MN (April 6, 2015) Ambient Clinical Analytics announced today it received 510(k) U.S. Food and Drug Administration (FDA) clearance for AWARE. AWARE is a clinical decision support tool, combined with a scientifically supported EMR viewer. The product reduces clinician information overload by using analytics to filter relevant patient data and provide timely, actionable information. The goal of the product is to clearly and concisely present actionable information to all care team members to improve patient outcomes, reduce the cost of care, and support best-care practices for ICUs and other critical care areas.
The FDA 510(k) clearance is for Class 2 medical devices that provide analytics-based clinical decision support beyond that provided by Class 1 viewers and dashboards.
“FDA clearance is an important step for Ambient Clinical Analytics in providing a comprehensive clinical decision support system that is available for installation today. We are excited to be launching AWARE at HIMSS15”, said Al Berning, CEO.
AWARE is a pivotal technology in Ambient’s portfolio of technologies, licensed from Mayo Clinic, that are changing the way critical care providers operate.
Trying to determine if a digital health app or wearable is a FDA regulated medical device? kBLASTER® search can help determine the FDA jurisdiction status of your digital health product. Leverage kBLASTER® consulting experience on FDA guidances regarding mobile medical applications, general wellness products and medical device data systems to navigate a path for a non-FDA regulated product.
Looking for the cornerstone to a successful 510(k) clearance strategy? kBLASTER® FDA 510(k) search can quickly identify the best available primary predicate, multiple predicates or reference devices and manage those results effectively.